Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
暂无分享,去创建一个
Kazuhiko Yamamoto | N. Miyasaka | J. Azuma | T. Kishimoto | T. Takeuchi | N. Nishimoto | S. Kawai | K. Yamamoto | Kazuhiko Yamamoto